Full Text View
Tabular View
No Study Results Posted
Related Studies
Hyperthermia European Adjuvant Trial (HEAT)
This study is not yet open for participant recruitment.
Verified March 2010 by Klinikum der Universitaet Muenchen, Grosshadern
Study NCT01077427   Information provided by Klinikum der Universitaet Muenchen, Grosshadern

First Received on February 25, 2010.   Last Updated on March 15, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pancreatic Adenocarcinoma
Additional conditions recognized in this trial
Adenocarcinoma
Fever
More general conditions related to this trial
Body Temperature Changes
Carcinoma
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Glandular and Epithelial
Signs and Symptoms
Interventions listed in this trial
Gemcitabine + regional hyperthermia
Gemcitabine
More general drug interventions related to this trial
Anti-Infective Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antiviral Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Klinikum der Universitaet Muenchen, Grosshadern
European Society for Hyperthermic Oncology
Institute for Medical Informatics, Biometry and Epidemiology, Munich
ClinAssess GmbH, Leverkusen, Germany


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services